The medical device industry posted modest job gains last year, and the industry is getting "purer" as more companies spin out their pharmaceutical divisions.
Last year may not have been a blockbuster one for medical device makers, but the industry posted steady gains in jobs, according to a new report from EP Vantage.
The analysis of nearly 100 small and large medtech companies found that jobs increased, on average, across the board. A closer look at the top 15 device makers found that jobs increased 6% overall and only 3 of the titans reduced their total headcount during the year, 2 of them by spinning out their pharma divisions.
Scorned Biolase ex-CEO Federico Pignatelli withdraws his lawsuit as the company urges shareholders to welcome new leadership and deny his bid for re-election to the board.
Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli agreed this week to withdraw his lawsuit against the dental devices maker, but he's still pursuing his personal investigation into the company's recent conduct.
RBC is also the exclusive provider of AdvantageRF - a portfolio of flexible mix and match solution tools for RF product developers that reduce risks, enhance reliability and sustainability, as well as accelerate time to market and lower R & D costs.